Vol 75, No 12 (2017)
Letters to the Editor
Published online: 2017-12-15
Drug action(s), drug marketing, and clinical medicine. Suppression of ventricular arrhythmogenicity with If blockade in human heart failure: emerging clinical evidence for ivabradine treatment benefit beyond heart rate control
DOI: 10.5603/KP.2017.0238
Kardiol Pol 2017;75(12):1368-1371.
Abstract
Not available
